Ryan White Clinics for 340B Access told a federal district judge last week it needs time to assess how proposed new 340B administrative dispute resolution regulations, if finalized, could affect the 340B overcharging claims it brought against AstraZeneca under the current ADR process and its related lawsuit that helped pressure the federal government to implement that process.
RWC-340B and the federal government submitted a status report on Dec. 1 in federal district court in Washington, D.C., in the group’s ongoing lawsuit. The advocacy group’s suit, which was filed in October 2020, helped force the government to issue and implement the existing ADR rules.
Ryan White Clinics for 340B Access told a federal district judge last week it needs time to assess how proposed new 340B administrative dispute resolution regulations, if finalized, could affect the 340B overcharging claims it brought against AstraZeneca under the current ADR process and its related lawsuit that helped pressure the federal government to implement that process.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
